PDS Biotechnology Corp Quarterly Debt-to-equity in % from Q3 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
PDS Biotechnology Corp quarterly Debt-to-equity history and growth rate from Q3 2021 to Q3 2024.
  • PDS Biotechnology Corp Debt-to-equity for the quarter ending September 30, 2024 was 108 %, a 22.8% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 108 +20 +22.8% Sep 30, 2024
Q2 2024 107 +34.6 +47.6% Jun 30, 2024
Q1 2024 107 +56.8 +112% Mar 31, 2024
Q4 2023 101 +64.9 +183% Dec 31, 2023
Q3 2023 87.7 +68.6 +359% Sep 30, 2023
Q2 2023 72.7 +65.3 +883% Jun 30, 2023
Q1 2023 50.6 +43.9 +654% Mar 31, 2023
Q4 2022 35.6 +28.7 +419% Dec 31, 2022
Q3 2022 19.1 +11.1 +138% Sep 30, 2022
Q2 2022 7.39 Jun 30, 2022
Q1 2022 6.71 Mar 31, 2022
Q4 2021 6.86 Dec 31, 2021
Q3 2021 8.03 Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.